<DOC>
	<DOCNO>NCT00533026</DOCNO>
	<brief_summary>To evaluate blood clot effect multiple dos warfarin steady state take time multiple dos duloxetine measure change International Normalised Ratio . All subject begin dose warfarin , approximately 12 day , duloxetine 60 mg add subject stabilize INR either continue dose 60 mg dose increase 120 mg .</brief_summary>
	<brief_title>Duloxetine - Warfarin Pharmacodynamic Study</brief_title>
	<detailed_description />
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Healthy men woman age 18 64 year . Have personal history , family history , current evidence : bleeding disorder , Positive Faecal Occult Blood ( FOB ) sample screening , significant neuropsychiatric disease ( include history suicide attempt exhibit suicidal ideation significant risk commit suicide , judge investigator ) , significant active respiratory , hepatic , renal , gastrointestinal , endocrine , hematological , neurological disorder . Use intend use aspirin NSAIDs within 2 week prior first dose . Subjects average weekly alcohol intake exceed 28 unit per week ( male ) 21 unit per week ( female ) . Subjects smoke 5 cigarette per day . Use intend u drug inhibits induces CYP1A2 inhibits CYP2D6 within 2 week prior first dose occasion study . Have receive drug act monoamine oxidase inhibitor ( MAOI ) within 2 week prior first dose occasion potential need use MAOI conduct study within 2 week discontinuation study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>